“Obesity/Overweight Treatment”的搜索结果，显示 321-330 项，共有 8926 项

1. 甲状腺疾病：对情绪有什么影响？ - 妙佑医疗国际

   < pan>fr13d i cde=e-siu;catetai)iving-tottz5.707 13d i cde=e-siz5.707 13d i cde=e-siz5.707 13d i cde=e-siz5.707 13d i cde=e-siz5.707 13d i cde=e-siu ...

2. 血液科- 临床试验- 妙佑医疗国际

   ... treatment of R/R Multiple Myeloma (MM). This study includes 2 parts ... treatment, in order to classify patients into post-consolidation treatment groups.

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Vaccine (H2NVAC) Before Surgery For The Treatment Of HER2-Expressing Ductal Carcinoma In Situ ... In addition, obesity, a chronic inflammatory ... Diet rich in ...

4. 外科 - 临床试验- 妙佑医疗国际

   ... treat brain tumors. CTSN Embolic Protection Trial. Rochester, Minn. The purpose of this study is to analyze the effectiveness and safety of an embolic ...

5. 外科 - 临床试验- 妙佑医疗国际

   This phase Ib trial studies the side effects and best dose of a vaccine called H2NVAC before surgery in treating patients with HER2 expressing ductal carcinoma ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma that has come ...

7. 外科 - 临床试验- 妙佑医疗国际

   ... treatment or patients that are experiencing an upper digestive disease in order to standardize and validate outcome measures. Data will be used to establish ...

8. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, ...

9. 神经科- 临床试验- 妙佑医疗国际

   To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the latest revised criteria in 2015 by ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...